Travere Therapeutics director Jeffrey A. Meckler disposes of common shares worth $1.31 million - TVTX News | RalliesTravere Therapeutics director Jeffrey A. Meckler disposes of common shares worth $1.31 million
T
TVTX• Insider transaction details
- Travere Therapeutics director Jeffrey A. Meckler exercised stock options on Sep. 10, 2026 for 20,000 common shares at USD 17.44–26.52.
- He sold 20,000 common shares the same day at weighted average prices of USD 65.39–68.09.
- Directly held common shares fell to 91,500 following the transactions.
NAUT
•
